Trial Details

UNKNOWN
Basic Information
Clinical ID c970
Identifier NCT04023396
Trial Title Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: ABX464
Participant Information
Sponsor Abivax S.A.
City Innsbruck
Country/Region Austria
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2020-01-13
Primary Completion Date 2025-12-22
Completion Date 2025-03-23